Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
ARE — Alexandria Real Estate Equities, Inc.
NYSE
FULL STOCK PAGE →

Alexandria Real Estate Equities (ARE) Q3 2025 Earnings Call Summary

OCT 28, 2025 2 MIN READ
REVENUE
$735.8M -0.2%
NET MARGIN
-31.6% -17.1 PTS
EPS
-$1.38 -115.6%
FREE CASH FLOW
$433.5M -5.8%

1Key Financial Results and Metrics

FFO per Share:: $2.22 for Q3 2025, a decline attributed to lower occupancy and rental income adjustments.

Occupancy Rate:: 90.6%, down 110 basis points on an apples-to-apples basis due to oversupply in certain submarkets.

Same-Property NOI:: Decreased by 6%, reflecting lower occupancy.

Leasing Activity:: Completed 1.2 million square feet, consistent with the five-quarter average.

Rental Rate Growth:: Renewals grew by 15.2% and re-leasing by 6.1% on a cash basis.

G&A Costs:: Reduced to 5.7% of NOI, aiming for $49 million in annual savings compared to 2024.

2Strategic Updates and Business Highlights

Alexandria is transitioning from a substantial development model to a build-to-suit approach, focusing on Megacampus developments.

The company aims to reduce non-income-producing assets from 20% to 10-15% of gross assets.

A historic lease was signed for 500,000 square feet at Campus Point Megacampus in San Diego, highlighting strong tenant relationships.

The company is prioritizing its balance sheet health, with over $4 billion in liquidity and a long average debt maturity of 11.6 years.

3Forward Guidance and Outlook

2025 Guidance:: FFO per share adjusted to a midpoint of $9.01, down $0.25 due to lower investment gains and same-property performance.

Occupancy Outlook:: Expected to range between 90% to 91.6% by year-end 2025.

2026 Considerations:: Detailed guidance will be provided at the Investor Day on December 3, 2025. Key trends impacting 2026 include core operations, capitalized interest, realized gains, and G&A costs.

4Bad News, Challenges, or Points of Concern

Government Shutdown:: The ongoing shutdown is severely impacting the FDA's operations, which is critical for the life sciences sector.

Occupancy Decline:: Continued oversupply in certain markets is pressuring occupancy rates and same-property NOI.

Market Conditions:: The biotech sector remains in a bear market, affecting demand and capital availability for tenants.

Impairments:: Recognized $323.9 million in impairments, primarily from a Long Island City redevelopment project that has not met expectations.

5Notable Q&A Insights

Tenant Activity:: While there is interest from high-quality companies, decision-making is slow due to economic uncertainty and high costs of capital.

Future Development:: Alexandria is cautious about its development pipeline, indicating a shift towards more strategic land sales and fewer new projects.

Equity Considerations:: Management expressed confidence in managing capital needs through asset sales rather than equity raises, given the strength of the balance sheet.

Market Dynamics:: The company is seeing varied demand across submarkets, with some areas remaining well-balanced while others are oversupplied. Overall, Alexandria Real Estate Equities is navigating a challenging environment marked by regulatory hurdles and market pressures, while strategically positioning itself for future growth through careful management of its assets and tenant relationships.

SOURCE: Q3 2025 EARNINGS CALL TRANSCRIPT